An agent of change

in the Canadian rare disease treatment ecosystem. Through its strategic partnerships, Médunik Canada commercializes and develops its own orphan drugs thereby offering new therapeutic options to improve the health and quality of life of Canadians suffering from rare diseases.

What is a rare disease?

An illness that affects a small percentage of the population, thereby limiting research, clinical expertise and patient access to effective treatment options

What is an orphan drug?

A medication or other medicinal product used to treat a rare disease or disorder

Please enter the email address for your account. A verification code will be sent to you. Once you have received the verification code, you will be able to choose a new password for your account.